Burney Company’s Rigel Pharmaceuticals RIGL Stock Holding History

Burney Company’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Sell	55,769 -35,914	-39%	-$1.11M	0.06%	227
2026 Q1	$2.48M	Buy	+91,683	New	+$3.08M	0.08%	194
2023 Q4	–	Sell	-3,500	Closed	-$37.8K	–	598
2023 Q3	$37.8K	Hold	3,500	–	–	﹤0.01%	561
2023 Q2	$45.1K	Hold	3,500	–	–	﹤0.01%	570
2023 Q1	$46.2K	Hold	3,500	–	–	﹤0.01%	556
2022 Q4	$52.5K	Hold	3,500	–	–	﹤0.01%	539
2022 Q3	$41K	Buy	3,500 +300	+9%	+$4.06K	﹤0.01%	541
2022 Q2	$36K	Hold	3,200	–	–	﹤0.01%	538
2022 Q1	$96K	Hold	3,200	–	–	﹤0.01%	565
2021 Q4	$85K	Hold	3,200	–	–	﹤0.01%	575
2021 Q3	$116K	Hold	3,200	–	–	0.01%	565
2021 Q2	$139K	Hold	3,200	–	–	0.01%	581
2021 Q1	$109K	Hold	3,200	–	–	0.01%	554
2020 Q4	$112K	Hold	3,200	–	–	0.01%	515
2020 Q3	$77K	Hold	3,200	–	–	﹤0.01%	493
2020 Q2	$59K	Hold	3,200	–	–	﹤0.01%	475
2020 Q1	$50K	Hold	3,200	–	–	﹤0.01%	420
2019 Q4	$68K	Buy	+3,200	New	+$65.9K	﹤0.01%	457
2018 Q3	–	Sell	-2,500	Closed	-$71K	–	465
2018 Q2	$71K	Buy	+2,500	New	+$89K	﹤0.01%	440
2018 Q1	–	Sell	-2,500	Closed	-$97K	–	442
2017 Q4	$97K	Buy	+2,500	New	+$95.1K	0.01%	429

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Burney Company's RIGL Position: Q2 2026 in Review

Burney Company reduced its Rigel Pharmaceuticals (RIGL) stake by 39% in Q2 2026, selling an estimated $1.11M and leaving 55,769 shares worth $2.18M. The position accounts for 0.06% of the portfolio, ranked #227.

Burney Company first reported a position in RIGL in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.48M in Q1 2026. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

Burney Company held 55,769 shares of Rigel Pharmaceuticals worth $2.18M as of Q2 2026.
Burney Company sold 35,914 Rigel Pharmaceuticals shares in Q2 2026, an estimated $1.11M.
Rigel Pharmaceuticals made up 0.06% of Burney Company's portfolio in Q2 2026, its #227 holding.
Burney Company first reported a position in Rigel Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
Burney Company's Rigel Pharmaceuticals position peaked at $2.48M in Q1 2026.
156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.